E-Cigarette Maker Juul Eyes Strategic Alternatives With Philip Morris, Japan Tobacco, Altria
E-Cigarette Maker Juul Eyes Strategic Alternatives With Philip Morris, Japan Tobacco, Altria
电子烟制造商 Juul 着眼于菲利普·莫里斯、日本烟草、奥驰亚的战略替代方案
- Lately, e-cigarette maker Juul Labs Inc had separate discussions with Philip Morris International Inc (NYSE:PM), Japan Tobacco (OTC:JAPAF) (OYTC: JAPAY), and Altria Group, Inc (NYSE:MO) over a potential sale, investment or partnership.
- Altria, which owns a 35% stake in Juul, valued the vaping company at $1 billion in October, the Wall Street Journal reports.
- Juul, which represents 27% of e-cigarettes sold in U.S. stores tracked by Nielsen, was on the verge of bankruptcy in 2022 amid a regulatory dispute over its existence in the U.S. market.
- The U.S. pursued a federal ban on menthol cigarettes. California has already banned menthols.
- The U.S. proceeded to eliminate nearly all nicotine from cigarettes.
- As federal regulators revamped the industry, big tobacco companies competed to grab pieces of the U.S. e-cigarette market.
- The FDA in June ordered Juul to halt its U.S. sales which neared the settlement of lawsuits accusing it of marketing its products to children and teens.
- Juul reached talks with Altria last fall on a potential deal to sell Juul's international business or license its U.S. intellectual property. Still, those talks fell apart in September as Juul prepared for a possible bankruptcy.
- Last September, Altria shared plans to end the agreement with Juul, which helped the latter prepare for its sale.
- In January, Juul CEO K.C. Crosthwaite and other executives traveled to Switzerland, where Japan Tobacco and Philip Morris are based, to discuss Juul's newly expanded option.
- Juul has also resumed discussions with Altria. Altria cannot buy Juul outright over antitrust concerns.
- If the FDA ultimately halts Juul's sales, Juul could seek U.S. authorization for a newer version of its vaporizer released in Canada and the U.K.
- Price Action: MO shares traded higher by 0.11% at $44.98 in the premarket on the last check Thursday.
- 最近，电子烟制造商 Juul Labs Inc 与他进行了单独的讨论 菲利普·莫里斯国际公司 （纽约证券交易所代码：PM）， 日本烟草 （场外交易代码：JAPAF）（OTC：JAPAY），以及 奥驰亚集团有限公司 (NYSE: MO) 就潜在的出售、投资或合作进行讨论。
- 据《华尔街日报》报道，拥有Juul35％股份的奥驰亚在10月份对这家电子烟公司的估值为10亿美元。
- Juul占尼尔森追踪的美国商店销售的电子烟的27％，由于有关其在美国市场的存在存在的监管争议，Juul在2022年濒临破产。
- 美国要求联邦政府禁止使用薄荷香烟。加州已经禁止使用薄荷醇。
- 美国开始从香烟中消除几乎所有的尼古丁。
- 随着联邦监管机构改革该行业，大型烟草公司竞相抢占美国电子烟市场的份额。
- 美国食品药品管理局在6月下令Juul停止在美国的销售，指控其向儿童和青少年销售其产品的诉讼已接近和解。
- 去年秋天，Juul与Altria就出售Juul的国际业务或许可其美国知识产权的潜在协议进行了会谈。尽管如此，由于Juul为可能的破产做准备，这些谈判在9月份破裂了。
- 去年9月，奥驰亚与Juul分享了终止协议的计划，这有助于后者为出售做准备。
- 1月，Juul首席执行官K.C. Crosthwaite和其他高管前往日本烟草和菲利普·莫里斯所在的瑞士，讨论Juul新扩大的选择。
- Juul 还恢复了与 Altria 的讨论。 出于反垄断考虑，奥驰亚无法直接收购Juul。
- 如果美国食品药品管理局最终停止Juul的销售，Juul可能会寻求美国的授权，以获得在加拿大和英国发布的新版本的蒸发器。
- 价格走势： 周四的最后一次盘前交易中，MO股价上涨0.11％，至44.98美元。